• 대한한방소아과학회지
• /
• 제32권4호
• /
• pp.42-50
• /
• 2018

Objectives The purpose of this study is to report a case of one autism spectrum disorder child who was treated by Korean medicine treatment. Methods The subject was a male child with autism spectrum disorder. This patient was treated with oriental herbal medicine and acupuncture. The improvement was observed by K-CARS. Results Korean medicine treatment relieved an autism spectrum disorder child's symptoms. For example, emotional excitement, hyperactivity disorder and repetition behavior are improved. K-CARS score at the initial stage of the treatment was 48 points, which can be considered as severe autistic. After 27 months of the treatment, the K-CARS was 26 points which is not autistic. There was no side effect reported. Conclusions This study showed that Korean medicine can be an effective treatment option for autism spectrum disorder.

• 대한약침학회지
• /
• 제19권1호
• /
• pp.28-36
• /
• 2016

Objectives: The purpose of this study is to achieve a vision for autistic children and their parents aimed at generating interest in ideas such as "Sanitas Per Aquam" (SPA), massage and music therapy, which has begun to have widespread use and to attract attention. Methods: This cross-sectional, descriptive study was carried out with autistic children and their parents from February to April 2015 in $Mu{\breve{g}}la$, Turkey. The study was began by interviewing experts in the field and by developing a suitable assessment questionnaire. In order to direct the flow of conversation between the researchers and the autisitc children and their parents, the researchers conducted semi-structured face to face interviews in a form that had been determined by using reports in the literature and the opinions of experts in the field. Results: Forty two boys (84%) and eight girls (16%) with autism participated in our study. Children in the 0 - 7 age group spent long time in the bathroom (P = 0.001). Boys liked to be hugged more than girls (P = 0.01). Children ages 0 - 7 years liked bright lighting while those 15 years of age and older liked gloomy lighting (P = 0.009). Except for these statistically significant sex- and age-related differences, no other statistically significant differences were noted in the parameters of this study. Although the result was not statistically significant, more children with mild autism disorder obeyed commands like inhale or exhale (P = 0.051). Conclusion: Treatment for autism spectrum disorders is not yet fully possible, so many studies are being done to alleviate some symptoms and to improve the quality of life for individuals with autism and their families. As a result of our study, whether touching the areas the children want touched and listening to their favorite music are required to stimulate the brain remain as questions in our minds.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제2권1호
• /
• pp.66-75
• /
• 1991

자폐장애의 유전적 요소를 조사하기 위하여 DSM-III-R의 진단기준으로 자폐장애에 부합한 38명의 아동에서 염색체 검사를 실시하였다. 본 연구의 대상은 남아 28명과 여아 10명이었으며, 평균 연령은 $108.8{\pm}28.5개월(70{\sim}156개월)$이었다. 염색체 핵형검사 결과 모든 대상 아동에서 46XX 혹은 46XY로서 염색체 수에는 이상이 없었다. Fragile X는 한 명에서도 발견되지 않았다. Fragile X 이외의 염색체 구조의 이상은 14명(36.8%)에서 발견되었으며, 그 양상은 breakage 11명, gap 2명, breakage와 gap이 공존하는 경우 1명이었다. Denver의 염색체 분류에 의한 이상 염색체 군은 A군 4명, C군 3명, 두 군 이상의 이상은 A군과 B군 동시에 발견된 경우가 1명, A군과 C군 동시 발견이 3명, A군과 E군 동시 발견이 1명, C군과 E군 동시 발견이 1명, A군 B군과 C군 동시 발견이 1명이었다. 염색체 구조에 이상이 있는 집단과 이상이 없는 집단을 DSM-III-R에 의한 자폐장애 증상 항목별로 비교하여 본 바, 모든 증상의 빈도는 양 집단간에 통계적으로 유의한 차이가 없었다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제2권1호
• /
• pp.76-86
• /
• 1991

유아자폐증의 생화학적인 원인중의 일부를 규명하기 위하여 전형적 유아자폐증 37명, 비전형 유아자폐증 26명, 대조군 23명을 대상으로 하여 혈장 DBH활성도를 측정하고, DBH 활성도와 연령 또는 정신병리와의 상관관계를 연구한 결과 다음과 같은 결과를 얻었다. 1) 혈장 DBH 활성도는 전형적 유아자폐증군에서 대조군에 비하여 현저히 높았으며, 전반적 발달 장애군(전형적 유아자폐증+비전형 유아자폐증)에서 대조군에 비하여 뚜렷이 높았다. 2) 혈장 DBH 활성도의 연령에 따른 변화는 비전형 유아자폐증군과 대조군에서는 연령이 증가됨에 뚜렷이 증가되는 양상을 보였으나, 전형적 유아자폐증군에서는 의미있는 상관관계가 관찰되지 않았다. 3) 혈정 DBH 활성도와 정신병리간의 상관관계는 의미있는 관계가 관찰되지 않았다. 이러한 결과로 미루어, 유아자폐증의 생화학적인 원인중의 일부로서 Catecholamine계가 관여하고 있을 가능성을 시사할 수 있으며, 이는 DBH의 개체발생적인 과정에서의 장애때문인 것으로 생각된다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제25권4호
• /
• pp.187-195
• /
• 2014

Objectives : The objective of this study was to investigate the relationship between restricted, repetitive behaviors and interests (RRBI) and autistic symptoms in Korean high functioning autism spectrum disorder (ASD) children and to examine the structure of RRBI. Methods : Participants included 147 high functioning ASD subjects and 181 unaffected siblings. ASD subjects were divided into two groups based on the presence of RRBI. The domain scores of the Korean version of Autism Diagnostic Interview-Revised (K-ADI-R), Korean version of Asperger Syndrome Diagnostic Scale and total scores of Korean translated version of Social Responsiveness Scale, Korean version of Social Communication Scale were used for comparison of ASD symptoms between the groups. Eleven items from the RRBI domain of the K-ADI-R were used in principal axis factor analysis (PAF). Results : A statistically lower nonverbal IQ score was observed for ASD with RRBI than for ASD without RRBIs, and more social deficit, communication deficit, and behavioral and emotional problems were observed for ASD with RRBI compared to ASD without RRBI. Using PAF, two distinct factors were identified. 'Resistance to trivial changes in environment', 'Difficulty with minor changes in personal routine & environment', and 'Compulsion/ritual' were included as one factor. Conclusion : Analysis of the data suggests that the presence of RRBI in high functioning ASD is associated with a more severe presentation of autistic disorder. In addition, there appears to be heterogeneity within RRBI in autism except insistence on sameness.

• Clinical and Experimental Pediatrics
• /
• 제58권1호
• /
• pp.8-14
• /
• 2015

In patients with a language developmental delay, it is necessary to make a differential diagnosis for autism spectrum disorders (ASDs), specific language impairment, and mental retardation. It is important that pediatricians recognize the signs and symptoms of ASDs, as many patients with language developmental delays are ultimately diagnosed with ASDs. Pediatricians play an important role in the early recognition of ASDs, because they are usually the first point of contact for children with ASDs. A revision of the diagnostic criteria of ASDs was proposed in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) that was released in May 2013. The autism spectrum describes a range of conditions classified as neurodevelopmental disorders in the fifth edition of the DSM. The new diagnostic criteria encompasses previous elements from the diagnosis of autistic disorder, Asperger disorder, childhood disintegrative disorder, and pervasive developmental disorder-not otherwise specified. An additional change to the DSM includes synthesizing the section on social and communication deficits into one domain. In ASD patients, the appropriate behavioral therapies and rehabilitation treatments significantly affect the prognosis. Therefore, this makes early diagnosis and treatment very important. In conclusion, pediatricians need to be able to recognize the signs and symptoms of ASDs and be attentive to them in order to make an early diagnosis and provide treatment.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제5권1호
• /
• pp.41-53
• /
• 1994

1944년 Hans Asperger는 아동기에 사회적인 고립과 특이한 행동 양식을 보이는 400명의 증례를 보고하고 자폐적 병질(autistic psychopathy)이라 명명하였는데 이 아동들은 1943년 Kanner에 의하여 기술된 자폐 아동들과 여러 가지면에서 유사하였으나 임상적인 관찰에서 몇몇 현저한 차이를 나타냈다. 가장 주목할 만한 것은 정상 언어 발달과 지능 수준의 차이를 들 수 있다. 이후에 이들은 Asperger's syndrome([CD-10) 혹은 Asperger's disorder(DSM-IV)로 명명되었는데 이들은 자폐증과 연속선상에 있는 높은 기능 수행을 보이는 경한 형태의 발달장애로 보는 시각, 아동기 인격 장애의 특수한 형태로 보는 시각, 혹은 성인 정신분열증의 초기 아동기 행태로 보는 시각등이 있는데, 모두 그들 나름대로 연구 방법의 타당성과 결과 해석의 문제점을 안고 있다. ICD-10(1992)과 DSM-IV(1994)에서 전반적 발달 장애의 영역내에 새로이 독립된 진단 체계로써 확고히 자리한 지금에 와서도 이들 질환과 완전히 분리된 개념으로 간주하기에는 미흡한 실정이다. 저자는 이 질환의 현재 개념에 이르기까지의 역사적 고찰과 더불어 독립된 질환이냐의 논의점과 최근 연구 경향에 대해 문헌 고찰을 하였으며 이 증후군이 큰 맥락에서 사회적 본능(social instinct)에 결함이 있는 장애라는 견지에서 연계 질환들과의 관계를 도식적으로 요약해 보았다.

• Journal of Genetic Medicine
• /
• 제12권1호
• /
• pp.1-5
• /
• 2015

De novo variants (DNVs) can arise during parental germ cell formation, fertilization, and the processes of embryogenesis. It is estimated that each individual carries 60-100 such spontaneous variants in the genome, most of them benign. However, a number of recent studies suggested that DNVs contribute to the pathogenesis of a variety of human diseases. Applications of DNVs include aiding in clinical diagnosis and identifying disease-causing genetic factors in patients with atypical symptoms. Therefore, understanding the roles of DNVs in a trio, with healthy parents and an affected offspring, would be crucial in elucidating the genetic mechanism of disease pathogenesis in a personalized manner.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제2권1호
• /
• pp.87-96
• /
• 1991

자폐증의 임상증상 완화에 대한 Carbamazepine의 효과를 평가하기 위하여 위약으로 대조한 이중맹(placebo controlled double blind) 연구를 실시하였다. 연구대상 아동은 1989년 10월부터 1991년 11월까지 서울대학병원 어린이병원 소아정신과 외래를 방문한, DSM-III-R의 전반적 발달장애의 진단기준을 만족시키면서, 부모가 연구에 동의한 23명의 남아로 하였다. 또한 다른 내과적 혹은 정신과적 질환력을 갖지 않으며, 연구 시작전 적어도 2개월이상의 약물복용이 없는 기간을 갖도록 하였다. 연구 대상군의 Cabamazepine치료군과 위약군으로 할당을 무작위적 할당표에 의해 할당하였는데, 각각 12명, 11명이 해당되었다. 연구 대상 아동의 상태를 모르는(blind) 2명의 평가자에 의하여, 기초관찰 기간과 12주의 약물치료 기간후에 측정한 검사도구의 측정값의 변화와 약물에 대한 부작용을 보았다. 두 검사자간의 신뢰도는 .4875-.6613이었다. 기초 관찰기간시 두군사이의 사회 인구학적 변인 및 검사도구의 값은 유의한 차이가 없었다. 약물 치료 기간 종결시 측정한 검사도구의 값과 기초 관찰기간의 값을 비교한 결과, Autism Behavior Checklist상 전체 점수의 유의한 차이(P<.05), 즉 Carbamazepine치료군이 위약군보다 자폐증 증상의 완화정도가 큰 소견을 보였다. Vineland Social Maturation Scale에서는 두군 모두에서 약물 치료 기간동안 사회성숙도상의 발달이 유의한 정도(P<.005)로 있었다.

• Biomolecules & Therapeutics
• /
• 제24권3호
• /
• pp.207-243
• /
• 2016

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social and communication impairments, as well as repetitive and restrictive behaviors. The phenotypic heterogeneity of ASD has made it overwhelmingly difficult to determine the exact etiology and pathophysiology underlying the core symptoms, which are often accompanied by comorbidities such as hyperactivity, seizures, and sensorimotor abnormalities. To our benefit, the advent of animal models has allowed us to assess and test diverse risk factors of ASD, both genetic and environmental, and measure their contribution to the manifestation of autistic symptoms. At a broader scale, rodent models have helped consolidate molecular pathways and unify the neurophysiological mechanisms underlying each one of the various etiologies. This approach will potentially enable the stratification of ASD into clinical, molecular, and neurophenotypic subgroups, further proving their translational utility. It is henceforth paramount to establish a common ground of mechanistic theories from complementing results in preclinical research. In this review, we cluster the ASD animal models into lesion and genetic models and further classify them based on the corresponding environmental, epigenetic and genetic factors. Finally, we summarize the symptoms and neuropathological highlights for each model and make critical comparisons that elucidate their clinical and neurobiological relevance.